Kymera Therapeutics, Inc.
USD109.32
+1.20 (+1.11%)
CEO
Nello Mainolfi
IPO Date
2020-08-21
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$106.96
Prev. Close
$108.12
Day Low
$105.00
Day High
$111.96
52W Low
$36.65
52W High
$130.05
Market Cap
$8.99B
Volume
1.68M
| -13.5 |
| 31 Dec 2023 | FY | 100.0% | -187.0% | -37.2% | -25.5% | 0.21 | 4.73 | -10.1 |
| 31 Dec 2022 | FY | 100.0% | -330.6% | -31.6% | -25.7% | 0.04 | 5.88 | -8.7 |
| 31 Dec 2021 | FY | 100.0% | -137.6% | -21.8% | -16.5% | 0.04 | 4.88 | -30.4 |
| 31 Dec 2020 | FY | 100.0% | -134.0% | -16.1% | -9.4% | 0.06 | 2.73 | -60.6 |
| 31 Dec 2019 | FY | 71.9% | -1407.4% | 55.5% | -35.4% | -0.28 | 2.69 | -35.9 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | 62.3% | -48.5% | -0.02 | 8.92 | -69.0 |
| -18.9 |
| 30 Sept 2025 | Q3 | -2580.7% | -2973.0% | -8.7% | -7.5% | 0.09 | 7.38 | -15.0 |
| 30 Jun 2025 | Q2 | 81.8% | -667.6% | -7.9% | -6.8% | 0.09 | 8.32 | -11.5 |
| 31 Mar 2025 | Q1 | 100.0% | -296.7% | -8.3% | -7.1% | 0.11 | 8.49 | -8.4 |
| 31 Dec 2024 | Q4 | 100.0% | -956.9% | -8.5% | -7.2% | 0.11 | 7.53 | -11.4 |
| 30 Sept 2024 | Q3 | 100.0% | -1670.3% | -7.0% | -6.0% | 0.10 | 8.55 | -14.4 |
| 30 Jun 2024 | Q2 | 100.0% | -164.0% | -6.1% | -5.1% | 0.13 | 8.45 | -13.4 |
| 31 Mar 2024 | Q1 | 100.0% | -472.0% | -6.8% | -5.6% | 0.12 | 9.57 | -14.4 |
| 31 Dec 2023 | Q4 | 100.0% | -30.0% | -3.6% | -2.5% | 0.21 | 4.73 | -25.9 |